Thor Medical ASA (FRA:8NN) Beta: -0.9910 (As of Jun. 26, 2026)


FRA:8NN Thor Medical ASA FRA:8NN
21 GF Score
Price €0.38
! 2 Warning Signs
View Full Analysis

What is Thor Medical ASA Beta?

Thor Medical ASA FRA:8NN +2.42% 21 Beta is -0.9910 as of Jun. 26, 2026. GuruFocus rates FRA:8NN with a GF Score™ of 21/100. The stock has 2 warning signs investors should review.

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-06-26), Thor Medical ASA's Beta is -0.9910.


Thor Medical ASA  (FRA:8NN) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


Thor Medical ASA Beta Related Terms


Thor Medical ASA Beta Historical Data

* Premium members only.

The historical data trend for Thor Medical ASA's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Thor Medical ASA Beta Chart

Thor Medical ASA Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beta
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.90 2.44 2.16 1.90 4.47

Thor Medical ASA Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.16 1.60 1.90 -0.12 4.47

FRA:8NN vs VRTX, REGN, ALNY: Beta Comparison

For the Biotechnology subindustry, Thor Medical ASA's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Thor Medical ASA Beta vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Thor Medical ASA's Beta distribution charts can be found below:

* The bar in red indicates where Thor Medical ASA's Beta falls into.


FRA:8NN
21GF Score
Thor Medical ASA FRA:8NN
Beta is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Thor Medical ASA Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Frequently Asked Questions Learn more about Beta →
What does a Beta of -0.9910 mean?
Thor Medical ASA (FRA:8NN) has a Beta of -0.9910 as of Jun. 26, 2026. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Thor Medical ASA and its competitors.
Is Thor Medical ASA's Beta too high?
Thor Medical ASA's current Beta is -0.9910. Overall, Thor Medical ASA has a GF Score™ of 21/100, reflecting its overall financial health beyond just this single metric.
How does Thor Medical ASA's Beta compare to VRTX and REGN?
Thor Medical ASA's Beta of -0.9910 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beta for a Biotechnology company?
A good Beta depends on the Biotechnology industry context. However, Beta should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beta mean?
A high Beta can signal that a stock is expensive relative to its fundamentals. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Thor Medical ASA and its competitors. Thor Medical ASA's current Beta is -0.9910. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Thor Medical ASA stock overvalued right now?
Thor Medical ASA (FRA:8NN) has a current Beta of -0.9910. The current Beta is -0.9910. Thor Medical ASA's overall GF Score™ is 21/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beta calculated?
Beta is calculated from a company's financial statements. For Thor Medical ASA (FRA:8NN), the current Beta is -0.9910 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Thor Medical ASA Business Description

Other Exchanges TRMED:Norway0R6Y:UK
Address Drammensveien 167, Oslo, NOR, 0277
Thor Medical ASA is a Norway-based biopharmaceutical company. The company is a producer and supplier of alpha-particle emitters for cancer therapy. The production process is based on separation of natural occurring radioactive decay products from thorium. The Company is utilizing alpha-emitters in radiotherapy and cancer treatments using Pb-212, which can be produced from naturally occurring isotope Thorium-232 and Lead-212. It uses a proprietary production process that does not involve irradiation or nuclear reactors to produce alpha-emitting materials. These materials are used by radiopharmaceutical companies in the development of cancer therapies.
21GF Score

Get the complete analysis for FRA:8NN

Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.38
Price